0QSS.L - ERYTECH Pharma S.A.

LSE - LSE Delayed price. Currency in EUR
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.22
52-week change 3-15.84%
S&P500 52-week change 32.74%
52-week high 31.2884
52-week low 30.0000
50-day moving average 30.8859
200-day moving average 30.8199

Share statistics

Avg vol (3-month) 313.38k
Avg vol (10-day) 321.11k
Shares outstanding 517.94M
Implied shares outstanding 6N/A
Float 828.11M
% held by insiders 16.60%
% held by institutions 111.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin -3.43%
Operating margin (ttm)-408.41%

Management effectiveness

Return on assets (ttm)-30.14%
Return on equity (ttm)-0.98%

Income statement

Revenue (ttm)6.65M
Revenue per share (ttm)0.21
Quarterly revenue growth (yoy)571.50%
Gross profit (ttm)N/A
EBITDA -24.97M
Net income avi to common (ttm)-228k
Diluted EPS (ttm)-1.7330
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)38.79M
Total cash per share (mrq)1.25
Total debt (mrq)13.57M
Total debt/equity (mrq)57.76
Current ratio (mrq)3.65
Book value per share (mrq)0.76

Cash flow statement

Operating cash flow (ttm)-31.76M
Levered free cash flow (ttm)-21.08M